Unlocking the clock

Ravi Allada (left) and Kevin Keegan (right) getting into the rhythm of their analysis. Credit: Courtesy of Ravi Allada" />Ravi Allada (left) and Kevin Keegan (right) getting into the rhythm of their analysis. Credit: Courtesy of Ravi Allada In October 2004, just as the clocks were changing in Illinois, the focus of Kevin Keegan's graduate work on circadian clocks was changing, too. Keegan, a

Written byElie Dolgin
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

In October 2004, just as the clocks were changing in Illinois, the focus of Kevin Keegan's graduate work on circadian clocks was changing, too. Keegan, a PhD student at Northwestern University in Evanston, Ill., was developing computer code to analyze preliminary data coming out of a microarray study to find Drosophila circadian rhythm genes. "On a lark," he decided to test his code on some previous circadian gene-hunting studies.

Together with his supervisor, Ravi Allada, Keegan ran the data from those five reports through his pilot algorithm, and out popped a complete surprise: many new genes that the reports had missed and had never been implicated before in daily timing. "I totally didn't expect to find a number of novel genes," he says. Quickly, the original "side project" of sifting through the existing data to find the best set of circadian genes became a top priority.

The signature of a ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies